Gut Reactions: A New Frontier in Lupus Detection
“You don’t look sick.”
This is a phrase patients with autoimmune diseases hear all too often. This includes individuals with Systemic Lupus Erythematosus (SLE), a complex disease that can hide in plain sight. Despite its endless possibilities of symptoms and organ damage, SLE is notoriously difficult to diagnose. However, growing numbers of research studies are shedding light on new areas of detection
Systemic Lupus Erythematosus, otherwise known as SLE, is an autoimmune disease characterized by inflammation involving virtually any organ system. Although the causes are unknown, experts believe lupus is influenced by genetic, environmental, and immunological factors; unfortunately for patients, it takes several years to receive a diagnosis. Currently, doctors use markers such as complement levels (C3, C4) and anti-Smith antibodies to help confirm diagnosis and monitor disease activity; however, SLE remains hard to diagnose because so many of its symptoms overlap with other autoimmune diseases.
Getting diagnosed has been a struggle for autoimmune patients, particularly due to the 'invisibility' of the disease. The biomarkers mentioned above improve the chances of an accurate diagnosis, which increases the likelihood of receiving appropriate treatment and beginning to manage the disease effectively. As research continues to search for more reliable diagnostic tools and insights into lupus progression, recent studies have begun to explore a new frontier: the gut microbiota.
This is a phrase patients with autoimmune diseases hear all too often. This includes individuals with Systemic Lupus Erythematosus (SLE), a complex disease that can hide in plain sight. Despite its endless possibilities of symptoms and organ damage, SLE is notoriously difficult to diagnose. However, growing numbers of research studies are shedding light on new areas of detection
Systemic Lupus Erythematosus, otherwise known as SLE, is an autoimmune disease characterized by inflammation involving virtually any organ system. Although the causes are unknown, experts believe lupus is influenced by genetic, environmental, and immunological factors; unfortunately for patients, it takes several years to receive a diagnosis. Currently, doctors use markers such as complement levels (C3, C4) and anti-Smith antibodies to help confirm diagnosis and monitor disease activity; however, SLE remains hard to diagnose because so many of its symptoms overlap with other autoimmune diseases.
Getting diagnosed has been a struggle for autoimmune patients, particularly due to the 'invisibility' of the disease. The biomarkers mentioned above improve the chances of an accurate diagnosis, which increases the likelihood of receiving appropriate treatment and beginning to manage the disease effectively. As research continues to search for more reliable diagnostic tools and insights into lupus progression, recent studies have begun to explore a new frontier: the gut microbiota.
Possible Lupus Complications
Image Source: Tima Miroshnichenko
For instance, research done by Lingyue et al. has highlighted the gut microbiota as a key factor in the progression of SLE, particularly when imbalances, known as dysbiosis, occur within the microbial community. This dysbiosis can trigger abnormal immune responses, activating autoreactive T and B cells and increasing inflammation, an important aspect of lupus. Studies show that people with SLE have less gut microbial diversity than healthy individuals; they tend to have fewer beneficial bacteria and more harmful ones. Certain bacteria are more common in people with active SLE and are linked to higher disease activity. These changes can damage the intestinal barrier, allowing bacterial products to enter the bloodstream, which then worsens immune activation and may contribute to disease onset. Because of these interactions, the gut microbiota could be a potential biomarker for early diagnosis in the disease, overall disease progression monitoring, and personalizing treatments.When monitoring disease post-diagnosis, these biomarkers reappear in regular blood work. These traditional biomarkers often fluctuate and don’t always correlate directly with disease severity, making them unreliable in some patients. Currently, there are only a few biomarkers, but expanding the list to gut microbiota, for example, would allow greater insight into how SLE particularly affects patients and how we can further support them.
Beyond diagnostics, emerging evidence suggests that the gut microbiome may also influence how patients respond to treatment.
Furthermore, some common SLE medications, such as hydroxychloroquine and mycophenolate, while primarily used for immunosuppression, might indirectly improve gut health by reducing inflammation. The interplay between medications and the microbiomes is very complex, and exploring these relationships could be interesting in figuring out treatment for patients with SLE.
Overall, all these insights show the potential of gut microbiota not only being a biomarker for diagnosis but also as a modifiable target for treatment. As the link between the gut and immune system becomes clearer, treatments tailored to people living with SLE will likely become more effective and lead to a better quality of life.
Beyond diagnostics, emerging evidence suggests that the gut microbiome may also influence how patients respond to treatment.
Furthermore, some common SLE medications, such as hydroxychloroquine and mycophenolate, while primarily used for immunosuppression, might indirectly improve gut health by reducing inflammation. The interplay between medications and the microbiomes is very complex, and exploring these relationships could be interesting in figuring out treatment for patients with SLE.
Overall, all these insights show the potential of gut microbiota not only being a biomarker for diagnosis but also as a modifiable target for treatment. As the link between the gut and immune system becomes clearer, treatments tailored to people living with SLE will likely become more effective and lead to a better quality of life.
Featured Image Source: Monstera Production
RELATED ARTICLES
|
Vertical Divider
|
Vertical Divider
|
Vertical Divider
|